CorMedix Therapeutics
Rezafungin
invasive fungal diseases
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on Rezafungin for invasive fungal diseases is expected Date TBD.
Primary source
· SEC 8-K
verified 14h ago
“the companies anticipate a pre-NDA submission meeting with FDA in the coming months, followed by a target submission of a supplemental New Drug Application (sNDA) to the FDA in 2H26 based on the ReSPECT results”